Synchrony Financial, together with its subsidiaries, operates as a consumer financial services company in the United States. It provides credit products, such as credit cards, commercial credit products, and consumer installment loans. The company also offers private label credit cards, dual cards, co-brand and general purpose credit cards, short- and long-term installment loans, and consumer banking products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts to retail and commercial customers, as well as accepts deposits through third-party securities brokerage firms. In addition, it provides debt cancellation products to its credit card customers through online, mobile, and direct mail; healthcare payments and financing solutions under the CareCredit, Pets Best, and Walgreens brands; payments and financing solutions in the apparel, specialty retail, outdoor, music, and luxury industries; and point-of-sale consumer financing for audiology products and dental services. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through various channels, such as digital and print. It serves digital, health and wellness, retail, home, auto, powersports, jewelry, pets, and other industries. Synchrony Financial was founded in 1932 and is headquartered in Stamford, Connecticut.
Synchrony Financial (SYF) faces securities fraud investigations, creating investor uncertainty. Analysis of allegations, partnerships, financials, and market outlook. Actionable insights included.
Synchrony Financial (SYF) faces securities law investigations amid market volatility. Analysts suggest a potential trend reversal. This report dives deep into SYF's challenges and prospects.
Synchrony Financial (SYF) faces securities fraud investigations amidst market volatility. A GARP stock, but legal risks warrant caution. Stay informed on SYF stock and investor alerts.
Synchrony Financial (SYF) faces securities fraud investigations, raising concerns about financial disclosures. This analysis examines allegations, financial implications, and market impact, evaluating its GARP status amid uncertainty.
Synchrony Financial (SYF) faces securities fraud investigations and market comparisons to SoFi, impacting investor confidence and market outlook. A detailed analysis follows.
Synchrony Financial (SYF) faces securities law investigations and market volatility. This analysis examines allegations, financials, competition, and strategic outlook.
Detailed data-driven analysis of SYF's securities investigation, Q4 earnings miss, and market factors affecting its financial performance.
Comprehensive analysis of SYF's Q4 2024 results, legal investigations, and market trends impacting its future growth.